Orbimed Advisors - AEROVATE THERAPEUTICS INC ownership

AEROVATE THERAPEUTICS INC's ticker is AVTE and the CUSIP is 008064107. A total of 57 filers reported holding AEROVATE THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.7%.

Quarter-by-quarter ownership
Orbimed Advisors ownership history of AEROVATE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$10,271,540
-20.9%
756,9300.0%0.22%
-7.2%
Q2 2023$12,981,350
-15.0%
756,9300.0%0.24%
-21.7%
Q1 2023$15,267,278
-31.4%
756,930
-0.3%
0.30%
-29.6%
Q4 2022$22,254,522
+68.8%
759,540
-4.5%
0.43%
+73.9%
Q3 2022$13,181,000
+76.2%
795,000
+66.1%
0.24%
+80.1%
Q2 2022$7,480,000
-20.0%
478,579
-6.2%
0.14%
-10.5%
Q1 2022$9,347,000
+48.0%
509,949
-4.8%
0.15%
+87.7%
Q4 2021$6,316,000
-43.8%
535,7140.0%0.08%
-34.7%
Q3 2021$11,239,000
-8.1%
535,7140.0%0.12%0.0%
Q2 2021$12,230,000535,7140.12%
Other shareholders
AEROVATE THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
OUP Management Co., LLC 603,762$8,193,05018.42%
TCG Crossover Management, LLC 2,201,274$29,871,2884.40%
Atlas Venture Life Science Advisors, LLC 2,039,249$27,672,6094.29%
Sofinnova Investments, Inc. 3,758,686$51,005,3693.22%
GREAT POINT PARTNERS LLC 1,091,233$14,808,0322.70%
RA Capital Management 8,263,982$112,142,2362.21%
Cormorant Asset Management, LP 1,561,696$21,192,2151.24%
Frazier Life Sciences Management, L.P. 1,204,867$16,350,0451.09%
Octagon Capital Advisors LP 497,370$6,749,3111.04%
Ghost Tree Capital, LLC 201,197$2,730,2430.90%
View complete list of AEROVATE THERAPEUTICS INC shareholders